Post-ICU long term sequelae- defined as "post intensive care syndrome" (PICS) manifest with a wide spectrum of psychological and cognitive impairments, affecting over two-thirds of ICU survivors and leading to increased rehospitalization, health care costs, impaired quality of life (QoL), inability to return to work and burden for families. The prevalence of post-traumatic stress symptoms (PTSD), anxiety symptoms, and depression after ICU stay is high and has been demonstrated in up to 50% of post-ICU population. Therefore, over the last years, an important effort has been made for the development of ICU aftercare and follow-up clinics with the aim to detect and to minimize post-ICU sequelae and improve outcomes. However, the utility of these follow-up programs and their effect on outcome has not been completely demonstrated.
This is a single center, prospective observational study, which will be conducted at Policlinico San Martino Hospital, Genova, Italy. Patients admitted to the ICU from more than 72 hours will be consecutively included during a 2 years period. The primary objective is to assess the incidence of post-discharge mortality in patients admitted in ICU at 12 months. Secondary objectives include the evaluation at 3, 6 and 12 months of outcome of patients admitted in ICU assessing QoL, anxiety, depression, PTSD, physical ability, cognitive function, sleep disorder and return to previous life; Self- and observer reported cognitive disability at 6 and 12 months after ICU discharge; prognostic factors for poor outcome, and emotional and burden of care impact on the patient's caregivers.
Study Type
OBSERVATIONAL
Enrollment
196
Observational study, no intervention is required
Policlinico San Martino
Genova, Italy
RECRUITINGTo assess the incidence of post-discharge mortality in patients admitted in ICU.
using a neuropsychological evaluation
Time frame: 12 months
Cognitive outcome assessed through the MoCA scale, Montreal Cognitive Assessment
This is a scale including different tests regarding language, attention, naming giving a score from 0 (maximal cognitive dysfunction) and 30 ( no deficit)
Time frame: 12 months
Cognitive outcome assessed through HADS scale (Hospital Anxiety and Depression Scale)
Questionnaire with score from 0 (no issues) to 21 (maximal abnormalities) exploring depression and anxiety
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.